Arkolith/Insider Trading/IMNM/Form 4

Wagenheim Philip

DirectorImmunome Inc. (IMNM) · full profile →Form 4 · filed Mar 23, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.3M
Net Open-Market Flow
-$1.3M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 23, 2026Sell(S)28K$20.65$582K341K
Mar 20, 2026Sell(S)37K$20.47$753K369K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001405684-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML